DarioHealth to Host First Quarter 2019 Conference Call May 13, 2019
Earnings Discussion and Business Update Scheduled for 9:00 am EDT
NEW YORK and CAESAREA, Israel, May 7, 2019 /PRNewswire/ -- Global digital therapeutics innovation leader DarioHealth Corp. (NASDAQ: DRIO) today announced it will release its first quarter 2019 results on Monday, May 13, and host a conference call the same morning at 9:00 am EDT.
The Company will discuss its first quarter 2019 operating and financial results and its outlook for 2019.
The call will be hosted by Erez Raphael, Chief Executive Officer, Olivier Jarry, President and Chief Commercial Officer, and Zvi Ben-David, Chief Financial Officer.
The live call can be accessed by dialing 1-844-369-8770 or 1-862-298-0840 (international). Participants should ask for the DarioHealth Earnings Conference Call. The conference call will also be available via live webcast at: https://www.investornetwork.com/event/presentation/48858
Conference Call Details:
Date: Monday, May 13, 2019
Time: 9:00am EDT
Dial-in Number: 1-844-369-8770
International Dial-in Number: 1-862-298-0840
Webcast: https://www.investornetwork.com/event/presentation/48858
Participants are asked to dial-in approximately 10 minutes prior to the start of the event. A replay of the call will be available approximately two hours after completion through May 27, 2019. To listen to the replay, dial 1-877-481-4010 (domestic) or 1-919-882-2331 (international) and use replay passcode 48858. The webcast replay will be available through August 13, 2019.
About DarioHealth Corp.
DarioHealth Corp. (NASDAQ: DRIO) is a leading global Digital Therapeutics (DTx) company revolutionizing the way people manage their health across the chronic condition spectrum. By delivering evidence-based interventions that are driven by data, high-quality software and coaching, we developed a novel approach that empowers individuals to adjust their lifestyle in a personalized way. Our Cross Functional Team operates at the intersection of life sciences, behavioral science and software technology to deliver highly engaging therapeutic interventions. Already one of the highest rated diabetes solutions, its user-centric approach is loved by tens of thousands of consumers around the globe. DarioHealth is rapidly moving into new chronic conditions and geographic markets.
DarioHealth Corporate Contact:
Joao Mendes-Roter
VP Marketing
[email protected]
+1-347-767-4220
SOURCE DarioHealth Corp.
Share this article